Novavax NVAX Business Segments — Net income (loss)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Novavax's business segments — net income (loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Novavax's business segments — net income (loss)?
- Novavax (NVAX) reported business segments — net income (loss) of -$9.49M in Q1 2026.
- How has Novavax's business segments — net income (loss) changed year-over-year?
- Novavax's business segments — net income (loss) decreased by 101.8% year-over-year, from $518.65M to -$9.49M.
- What is the long-term trend for Novavax's business segments — net income (loss)?
- Over 3 years (2022 to 2025), Novavax's business segments — net income (loss) has grown at a -12.5% compound annual growth rate (CAGR), from -$657.94M to $440.3M.
- What does business segments — net income (loss) mean?
- Represents the final profit or loss generated by the reportable segment after accounting for all revenues, cost of sales, operating expenses, and other segment-specific items. It serves as the primary measure of the segment's overall financial health and its contribution to the company's total profitability.